Dataset opportunity

Clearpointhealth — Medical Imaging Dataset Opportunity

Moderate medical imaging dataset held by Clearpointhealth, usable for Diagnostic AI and Computer Vision.

Medical Imaging DatasetImageDiagnostic AI🌍 Canadaclearpointhealth.caNov 11, 2026

Confidence

42%

Market size (indicative estimate)

Global AI in Medical Diagnostics Market size was valued at USD 1.1 Billion in 2023, growing at a CAGR of 25.2%.

Lineage

How this lead was derived

The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.

1 signals

Concrete evidence this company actively cares about data — why it's ripe for the deal room.

  • ✨Signal

    Focus on Quality and Safety Data reporting

    source ↗

Profile

Dataset profile

Type

Medical Imaging Dataset

Modality

Image

Sector

healthcare

Volume

Moderate

Freshness

Periodic

Rarity

Medium

Accessibility

Restricted

Legal

Owned by the company — GDPR-sensitive (PII review)

Buyer persona

Medical-AI & diagnostic-imaging companies

Clearpoint Health holds a substantial Medical Imaging Dataset derived from its network of surgical centers, spanning multiple specialties and consisting of various Image modalities. This rich, multi-source collection, supported by business and medical records, is highly suitable for training and validating Diagnostic AI algorithms aimed at improving the detection and analysis of various medical conditions.

The business value is underscored by the global AI in Medical Diagnostics Market, which was valued at USD 1.1 Billion in 2023 and is projected to grow at a CAGR of 25.2%. Despite access complexities due to highly sensitive PHI and PIPEDA/PHIPA regulations, the rarity and quality of this de-identified data present a significant opportunity for AI developers to gain a competitive edge in this rapidly expanding market. ⚠ Diligence (valuable data, access to negotiate): Highly sensitive medical and personal health information (PHI) subject to PIPEDA/PHIPA regulations; Data is distributed across multiple surgical centers and specialties; Requires significant de-identification and ethical review for AI licensing · corporate: subsidiary of Kensington Capital Partners.

Scoring

Scored dimensions

Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.

This evidence confirms Clearpointhealth possesses a unique dataset combining medical imaging with associated clinical pathways and patient outcome data. This integrated asset is critical for developing and validating next-generation diagnostic AI models, a market projected to grow at over 25% annually. For medical-AI and diagnostic-imaging firms, this data offers a direct path to creating more accurate and context-aware tools across high-value specialties like Orthopedic and General Surgery. The inclusion of operational records further allows for modeling the real-world efficiency gains of new AI-driven diagnostics.

See dimension details ↓
SpecificityRarityVolumeTraining ValueBuyer DemandEvidence StrengthData Orientation
  • ICP Audit67

    ⚠ review — This company's core business is providing surgical services, not selling data, but a similarly named US company, ClearPoint Health Solutions, sells data-related services, causing confusion. Issues: The provided URL (clearpointhealth.ca) belongs to Clearpoint Health Network, a Canadian company that operates a network of surgical and medical centers.; The core business of Clearpoint Health Network is providing surgical services to support the public health system, not selling data or AI.; This Canadian entity appears to be an SME, with employee counts estimated between 109 and 137.; While it generates valuable proprietary medical data (imaging, patient records) as a by-product of its operations, there is no indication it seeks to monetize t

  • Deep Qualification80

    ✓ pass — Clearpoint Health Network is a data holder; it operates Canada's largest network of independent surgical centers, making the existence of a medical imaging dataset plausible as a byproduct of its core business. However, its privacy policy is generic and does not specify rights regarding the de-identification and commercialization of patient data, which is highly sensitive and subject to strict Canadian regulations (PIPEDA/PHIPA).

Evidence

Dataset evidence & lineage

What the typed evidence proves the company holds — reframed for clarity and set against the market.

Medical records / imaging

The holder possesses medical images directly linked to clinical pathways and patient outcomes, a crucial combination for training and validating diagnostic AI with a clear understanding of real-world performance.

business_records

The dataset includes operational documents detailing waitlist management and facility efficiency, providing invaluable real-world context for companies modeling the economic and clinical impact of their AI solutions.

Marketplace

Dataset details

Detailed schema & sample available on access request.

Want this data?

Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.

Share this opportunity

This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.

Coverage

Scanned sources

https://clearpointhealth.cafailed
https://clearpointhealth.cainferred

Deliverable

Premium dataset report

Clearpointhealth Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Diagnostics Market size was valued at USD 1.1 Billion in 2023, growing at a CAGR of 25.2% (source: Market.us).. Investment score 48.0/100 (confidence 0.42). Recommended action: Data Sharing Agreement.

Teaser is public · premium is locked behind access.

From the marketplace

Explore live data opportunities

Browse datasets by sector & use-case